Terns Pharmaceuticals, Inc. (TERN)
40.38
-1.12
(-2.70%)
USD |
NASDAQ |
Dec 30, 14:14
Terns Pharmaceuticals Total Liabilities (Quarterly): 17.58M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Altimmune, Inc. | 32.85M |
| Ligand Pharmaceuticals, Inc. | 526.60M |
| ADMA Biologics, Inc. | 137.50M |
| Viking Therapeutics, Inc. | 26.38M |
| Cidara Therapeutics, Inc. | 96.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 301.65M |
| Shareholders Equity (Quarterly) | 284.07M |
| Debt to Equity Ratio | 0.0036 |
| Current Ratio | 19.52 |
| Net Debt Paydown Yield | -0.02% |